New Drug Approval: Hope for Hand Eczema Sufferers

Delgocitinib, a new drug approved in England for treating moderate to severe chronic hand eczema, offers hope to over sixty-two thousand sufferers. This cream, applied twice daily, is expected to be available on the NHS within ninety days, potentially saving the healthcare system significant costs. Its particularly beneficial for those whose current treatments arent working, providing a new option for those who have found steroid creams ineffective or unsuitable. DNN | The Daily News Now! The world’s first global local news network. Every city. Every story. AI powered. Hosted on Acast. See acast.com/privacy for more information.